Yijun Deng

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection

P. Zheng, Baoqing Sun, C. Ke, 2022, Emerging microbes & infections.

Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation

Qian Wang, P. Zheng, Mingshan Xue, 2022, Frontiers in Immunology.

Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection

F. Hu, Q. Pan-Hammarström, Ling Chen, 2021, Journal of virology.

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

Xiao-Neng Mo, X. Xiong, Jian Han, 2021, Emerging microbes & infections.

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.

Yanqun Wang, Qiuluan Chen, Xuefeng Niu, 2024, Cell reports.

An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA

P. Zheng, Xuefeng Niu, Zhongfang Wang, 2024, JCI insight.